- Home
- Publications
- Publication Search
- Publication Details
Title
Current Advances in Immunotherapy for Glioblastoma
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 23, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-26
DOI
10.1007/s11912-020-01007-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
- (2020) David A. Reardon et al. CLINICAL CANCER RESEARCH
- The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review
- (2020) Cyrillo G. Brahm et al. Cancers
- Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma
- (2020) Jingyu Wang et al. Frontiers in Oncology
- Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
- (2020) Ekaterina Friebel et al. CELL
- Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
- (2020) Florian Klemm et al. CELL
- T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment
- (2020) Darwin Kwok et al. JOURNAL OF NEURO-ONCOLOGY
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma
- (2020) Sabine Mueller et al. JOURNAL OF CLINICAL INVESTIGATION
- Virus-Based Immunotherapy of Glioblastoma
- (2019) Miika Martikainen et al. Cancers
- Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma
- (2019) Mark W Kieran et al. NEURO-ONCOLOGY
- Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients
- (2019) Denis Migliorini et al. NEURO-ONCOLOGY
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
- (2019) Stephanie L. Goff et al. JOURNAL OF IMMUNOTHERAPY
- A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma
- (2019) Patrick Y. Wen et al. CLINICAL CANCER RESEARCH
- The Evolving Role of Antiangiogenic Therapies in Glioblastoma Multiforme: Current Clinical Significance and Future Potential
- (2019) Casey Anthony et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
- (2019) Juan Huang et al. Frontiers in Oncology
- Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns
- (2019) Huihui Ma et al. CANCER GENE THERAPY
- ATIM-14. RESULTS OF PHASE II CLINICAL TRIAL OF ONCOLYTIC HERPES VIRUS G47Δ IN PATIENTS WITH GLIOBLASTOMA
- (2019) Tomoki Todo NEURO-ONCOLOGY
- LTBK-08. TOCA 511 & TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
- (2019) Timothy Cloughesy et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
- (2019) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice
- (2019) Matthias Mulazzani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
- (2019) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells
- (2018) Sadhak Sengupta et al. CANCER LETTERS
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
- (2018) Georgina V Long et al. LANCET ONCOLOGY
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC
- (2018) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+T cell trafficking
- (2018) David Taggart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
- (2018) Michael M. Boyiadzis et al. Journal for ImmunoTherapy of Cancer
- Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
- (2018) Anandani Nellan et al. Journal for ImmunoTherapy of Cancer
- Designer Oncolytic Adenovirus: Coming of Age
- (2018) Alexander Baker et al. Cancers
- Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients.
- (2018) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 trial of SL-701 in relapsed/refractory (r/r) glioblastoma (GBM): Correlation of immune response with longer-term survival.
- (2018) David M. Peereboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
- (2018) Pakawat Chongsathidkiet et al. NATURE MEDICINE
- First results on the DCVax phase III trial: raising more questions than providing answers
- (2018) Wolfgang Wick et al. NEURO-ONCOLOGY
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
- (2018) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS
- (2018) Michael Platten et al. NEURO-ONCOLOGY
- ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)
- (2018) Gelareh Zadeh et al. NEURO-ONCOLOGY
- Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
- (2018) E Antonio Chiocca et al. NEURO-ONCOLOGY
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
- (2017) Zinal S. Chheda et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment
- (2017) Nakho Chang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- Immunosuppressive Myeloid Cells’ Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy
- (2017) Neha Kamran et al. MOLECULAR THERAPY
- Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
- (2017) Karsten Geletneky et al. MOLECULAR THERAPY
- A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
- (2017) Marta Łuksza et al. NATURE
- ATIM-18. A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC IRRADIATION (HFSRT) WITH PEMBROLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (NCT02313272)
- (2017) Solmaz Sahebjam et al. NEURO-ONCOLOGY
- Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
- (2017) Kevin Bielamowicz et al. NEURO-ONCOLOGY
- Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials
- (2017) Benjamin M. Ellingson et al. Neurotherapeutics
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selection
- (2017) Andrea M. Muscat et al. Oncotarget
- MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives
- (2017) Domenico Aquino et al. Journal of Immunology Research
- The Sequence of Delta24-RGD and TMZ Administration in Malignant Glioma Affects the Role of CD8 + T Cell Anti-tumor Activity
- (2017) Anne Kleijn et al. Molecular Therapy-Oncolytics
- Strategies and Approaches of Targeting STAT3 for Cancer Treatment
- (2016) Steffanie L. Furtek et al. ACS Chemical Biology
- Vascular basement membranes as pathways for the passage of fluid into and out of the brain
- (2016) Alan W. J. Morris et al. ACTA NEUROPATHOLOGICA
- Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
- (2016) Kole T. Roybal et al. CELL
- Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
- (2016) Leonardo Morsut et al. CELL
- Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer
- (2016) L. T. Lyle et al. CLINICAL CANCER RESEARCH
- New Strategies for the Treatment of Solid Tumors with CAR-T Cells
- (2016) Hao Zhang et al. International Journal of Biological Sciences
- Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
- (2016) Leonid Cherkassky et al. JOURNAL OF CLINICAL INVESTIGATION
- Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
- (2016) Meenakshi Hegde et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
- (2016) Michael D. Iglesia et al. JNCI-Journal of the National Cancer Institute
- Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
- (2016) Sarah B Goldberg et al. LANCET ONCOLOGY
- Metastasis in Adult Brain Tumors
- (2016) Ramon Francisco Barajas et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy
- (2016) Dickran Kazandjian et al. ONCOLOGIST
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
- (2016) Timothy F. Cloughesy et al. Science Translational Medicine
- Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
- (2016) Michael D. Iglesia et al. JNCI-Journal of the National Cancer Institute
- Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
- (2015) David A. Solomon et al. BRAIN PATHOLOGY
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
- (2015) Aleksanteri Aspelund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas
- (2015) Jun Yan et al. JNCI-Journal of the National Cancer Institute
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
- (2015) Hideho Okada et al. LANCET ONCOLOGY
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- DDEL-06PRELIMINARY SAFETY OF TOCA 511, A RETROVIRAL REPLICATING VECTOR, IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ACROSS THREE SEPARATE PHASE 1 STUDIES
- (2015) Steven N. Kalkanis et al. NEURO-ONCOLOGY
- Immunosuppressive mechanisms in glioblastoma: Fig. 1.
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- PD-L1 expression and prognostic impact in glioblastoma
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas
- (2015) Jun Yan et al. JNCI-Journal of the National Cancer Institute
- First oncolytic virus approved for melanoma immunotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- Oncolytic polio virotherapy of cancer
- (2014) Michael C. Brown et al. CANCER
- A microarray-based DNA methylation study of glioblastoma multiforme
- (2014) Ramon Martinez et al. Epigenetics
- Peptide vaccines for the treatment of glioblastoma
- (2014) Adam M. Swartz et al. JOURNAL OF NEURO-ONCOLOGY
- Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
- (2014) B. Thaci et al. NEURO-ONCOLOGY
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
- (2013) Zakaria Grada et al. Molecular Therapy-Nucleic Acids
- Molecular imaging of microglia/macrophages in the brain
- (2012) Sriram Venneti et al. GLIA
- Myeloid-derived Suppressor Cells (MDSCs) in Gliomas and Glioma-Development
- (2012) Gary Kohanbash et al. IMMUNOLOGICAL INVESTIGATIONS
- Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
- (2012) Omar D Perez et al. MOLECULAR THERAPY
- Assessment of Disease Activity in Multiple Sclerosis Phenotypes with Combined Gadolinium- and Superparamagnetic Iron Oxide–enhanced MR Imaging
- (2012) Thomas Tourdias et al. RADIOLOGY
- A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid
- (2012) J. J. Iliff et al. Science Translational Medicine
- Capture, crawl, cross: the T cell code to breach the blood–brain barriers
- (2012) Britta Engelhardt et al. TRENDS IN IMMUNOLOGY
- Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis
- (2011) Friederike Pfeiffer et al. ACTA NEUROPATHOLOGICA
- Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy
- (2011) Cheryl A. Hawkes et al. ACTA NEUROPATHOLOGICA
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
- (2011) Stuart A. Grossman et al. CLINICAL CANCER RESEARCH
- Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
- (2010) B. Jena et al. BLOOD
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulatory T cells exert checks and balances on self tolerance and autoimmunity
- (2009) Kajsa Wing et al. NATURE IMMUNOLOGY
- EGF receptor variant III as a target antigen for tumor immunotherapy
- (2008) Gordon Li et al. Expert Review of Vaccines
- Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology
- (2008) R. O. Carare et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma
- (2008) Shahriar S Yaghoubi et al. Nature clinical practice. Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started